BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND NPM1, NPM, 4869, ENSG00000181163, P06748, B23, MGC104254 AND Diagnosis
54 results:

  • 1. Understanding differential technologies for detection of MRD and how to incorporate into clinical practice.
    Cloos J; Ngai LL; Heuser M
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):682-690. PubMed ID: 38066915
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Blasts with folded nuclei: A histopathologic finding in myeloid leukemia cutis with npm1 and FLT3 mutations.
    Han S; Patel T; Garcia ML; Tirado M
    J Cutan Pathol; 2024 Feb; 51(2):130-134. PubMed ID: 37866827
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Phenotypic clues that predict underlying cytogenetic/genetic abnormalities in myeloid malignancies: A contemporary review.
    Stone M; Lilley CM; Tang G; Loghavi S; Mirza KM
    Cytopathology; 2023 Nov; 34(6):530-541. PubMed ID: 37522274
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Hypoplastic form of myelodysplastic neoplasm.
    Votavová H; Lenertová Z; Votava T; Beličková M
    Klin Onkol; 2023; 36(3):206-214. PubMed ID: 37353349
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia.
    Naldini MM; Casirati G; Barcella M; Rancoita PMV; Cosentino A; Caserta C; Pavesi F; Zonari E; Desantis G; Gilioli D; Carrabba MG; Vago L; Bernardi M; Di Micco R; Di Serio C; Merelli I; Volpin M; Montini E; Ciceri F; Gentner B
    Nat Commun; 2023 Mar; 14(1):1285. PubMed ID: 36890137
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A global study for acute myeloid leukemia with RARG rearrangement.
    Zhu HH; Qin YZ; Zhang ZL; Liu YJ; Wen LJ; You MJ; Zhang C; Such E; Luo H; Yuan HJ; Zhou HS; Liu HX; Xu R; Li J; Li JH; Hao JP; Jin J; Yu L; Zhang JY; Liu LP; Zhang LP; Huang RB; Shen SH; Gao SJ; Wang W; Yan XJ; Zhang XY; Du X; Chu XX; Yu YF; Wang Y; Mi YC; Lu Y; Cai Z; Su Z; Taussig DC; MacMahon S; Ball ED; Wang HY; Welch JS; Yin CC; Borthakur G; Sanz MA; Kantarjian HM; Huang JY; Hu J; Chen SN
    Blood Adv; 2023 Jul; 7(13):2972-2982. PubMed ID: 36799929
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Mutational profile, outcomes, and impact of allogeneic hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia and inconclusive cytogenetic analysis.
    Vasudevan Nampoothiri R; Tang K; Schuh A; Lam W; Maze D; Michelis FV; Chan S; Gupta V; Kim D; Kumar R; Lipton JH; Mattsson J; Minden M; Schimmer A; Sibai H; Viswabandya A; Yee K; Murphy T; Law AD
    Eur J Haematol; 2023 Jun; 110(6):618-625. PubMed ID: 36732677
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The International Consensus Classification of acute myeloid leukemia.
    Weinberg OK; Porwit A; Orazi A; Hasserjian RP; Foucar K; Duncavage EJ; Arber DA
    Virchows Arch; 2023 Jan; 482(1):27-37. PubMed ID: 36264379
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Myeloid Sarcoma of the Breast as Blast Phase of JAK2-Mutated (Val617Phe Exon 14p) Essential Thrombocythemia: A Case Report and a Systematic Literature Review.
    Pace M; Guadagno E; Russo D; Gencarelli A; Carlea A; Di Spiezio A; Bertuzzi C; Mascolo M; Grimaldi F; Insabato L
    Pathobiology; 2023; 90(2):123-130. PubMed ID: 35850113
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Acquired WT1 mutations contribute to relapse of npm1-mutated acute myeloid leukemia following allogeneic hematopoietic stem cell transplant.
    El Hussein S; DiNardo CD; Takahashi K; Khoury JD; Fang H; Furudate K; Lyapichev KA; Garces S; Kanagal-Shamanna R; Ok CY; Patel KP; Routbort MJ; Ravandi F; Medeiros LJ; Wang SA; Loghavi S
    Bone Marrow Transplant; 2022 Mar; 57(3):370-376. PubMed ID: 34992253
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Targeting CD33 for acute myeloid leukemia therapy.
    Liu J; Tong J; Yang H
    BMC Cancer; 2022 Jan; 22(1):24. PubMed ID: 34980040
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clinical impact of npm1-mutant molecular persistence after chemotherapy for acute myeloid leukemia.
    Tiong IS; Dillon R; Ivey A; Kuzich JA; Thiagarajah N; Sharplin KM; Kok CH; Tedjaseputra A; Rowland JP; Grove CS; Abro E; Shortt J; Hiwase DK; Bajel A; Potter NE; Smith ML; Hemmaway CJ; Thomas A; Gilkes AF; Russell NH; Wei AH
    Blood Adv; 2021 Dec; 5(23):5107-5111. PubMed ID: 34555849
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Deep learning detects acute myeloid leukemia and predicts npm1 mutation status from bone marrow smears.
    Eckardt JN; Middeke JM; Riechert S; Schmittmann T; Sulaiman AS; Kramer M; Sockel K; Kroschinsky F; Schuler U; Schetelig J; Röllig C; Thiede C; Wendt K; Bornhäuser M
    Leukemia; 2022 Jan; 36(1):111-118. PubMed ID: 34497326
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Prognostic impact of the adverse molecular-genetic profile on long-term outcomes following allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia.
    Daher-Reyes G; Kim T; Novitzky-Basso I; Kim KH; Smith A; Stockley T; Capochichi JM; Al-Shaibani Z; Pasic I; Law A; Lam W; Michelis FV; Gerbitz A; Viswabandya A; Lipton J; Kumar R; Mattsson J; Schimmer A; McNamara C; Murphy T; Maze D; Gupta V; Sibai H; Chan S; Yee K; Minden M; Zhang Z; Schuh A; Kim DDH
    Bone Marrow Transplant; 2021 Aug; 56(8):1908-1918. PubMed ID: 33767401
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Minimal Residual Disease Monitoring Using a 3'ALK Universal Probe Assay in ALK-Positive Anaplastic Large-Cell Lymphoma: ddPCR, an Attractive Alternative Method to Real-Time Quantitative PCR.
    Quelen C; Grand D; Sarot E; Brugières L; Sibon D; Pradines A; Laurent C; Brousset P; Lamant L
    J Mol Diagn; 2021 Feb; 23(2):131-139. PubMed ID: 33246076
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. How I diagnose and treat npm1-mutated AML.
    Falini B; Brunetti L; Martelli MP
    Blood; 2021 Feb; 137(5):589-599. PubMed ID: 33171486
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. npm1 and FLT3-TKD mutations are enriched in patients with leukemia cutis.
    Karagounis TK; Rotemberg V; Geskin LJ; Jurcic JG; MDAuthors GN
    Dermatol Online J; 2020 Jul; 26(7):. PubMed ID: 32898396
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Multiparametric in situ imaging of npm1-mutated acute myeloid leukemia reveals prognostically-relevant features of the marrow microenvironment.
    Patel SS; Lipschitz M; Pinkus GS; Weirather JL; Pozdnyakova O; Mason EF; Inghirami G; Hasserjian RP; Rodig SJ; Weinberg OK
    Mod Pathol; 2020 Jul; 33(7):1380-1388. PubMed ID: 32051557
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Targeted sequencing aids in identifying clonality in chronic myelomonocytic leukemia.
    Hwang SM; Kim SM; Nam Y; Kim J; Kim S; Ahn YO; Park Y; Yoon SS; Shin S; Kwon S; Lee DS
    Leuk Res; 2019 Sep; 84():106190. PubMed ID: 31377458
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Genetic alteration patterns and clinical outcomes of elderly and secondary acute myeloid leukemia.
    Wang SY; Cheng WY; Mao YF; Zhu YM; Liu FJ; Ma TT; Shen Y
    Hematol Oncol; 2019 Oct; 37(4):456-463. PubMed ID: 31348835
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.